Company intelligence / Profile preview

Shanghai Argo Biopharmaceutical Co., Ltd.

Shanghai, Shanghai, Chinaargobiopharma.com ↗

Ownership: Private
Development stage: Phase 2

Overview

The company has demonstrated well-tolerated safety profiles across its leading clinical programs. It has completed phase I trials for several siRNA candidates targeting cardiovascular conditions and initiated phase II studies. Its pipeline shows best-in-class potential leveraging the RADS platform to develop next-generation siRNA drugs aiming to reduce dosing frequency significantly.

Therapeutic areas: Metabolic DisordersRare DiseasesImmunologyCardiovascularNeurologyInfectious Diseases
Modalities: Small interfering RNA (siRNA)RNA interference (RNAi) therapeuticsChemical drugs (limited presence)
Industry: Biotech

Drug pipeline

24 assets

BW-20805

23 more assets in the full pipeline.

Request access →

Partnerships

Novartis PHARMA AG – multi-program exclusive license and collaboration agreements signed January 2024 involving cardiovascular disease assets with upfront payments of $185 million plus milestones and royalties. Novartis holds ex-Greater China rights on one program plus worldwide rights on another[7][8].

Beyond the preview

Go deeper on Shanghai Argo Biopharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Argo Biopharmaceutical Co., Ltd..

Explore the full profile